Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
about
Epidermal growth factor, latrophilin, and seven transmembrane domain-containing protein 1 marker, a novel angiogenesis markerKilling cancer with platycodin D through multiple mechanismsSequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic LandscapesThe Contribution of Angiogenesis to the Process of MetastasisBiomarkers of evasive resistance predict disease progression in cancer patients treated with antiangiogenic therapies.Unraveling the Anticancer Effect of Curcumin and ResveratrolMesenchymal Stromal Cells Can Regulate the Immune Response in the Tumor MicroenvironmentRevisiting the hallmarks of cancer.99mTc-labeled bevacizumab for detecting atherosclerotic plaque linked to plaque neovascularization and monitoring antiangiogenic effects of atorvastatin treatment in ApoE-/- micePredictive model of thrombospondin-1 and vascular endothelial growth factor in breast tumor tissueα-Mangostin, a Natural Agent, Enhances the Response of NRAS Mutant Melanoma to Retinoic Acid.Antiangiogenic effects of oridonin.Bone marrow derived myeloid cells orchestrate antiangiogenic resistance in glioblastoma through coordinated molecular networks.Gamabufotalin, a major derivative of bufadienolide, inhibits VEGF-induced angiogenesis by suppressing VEGFR-2 signaling pathway.BRAF kinase inhibitor exerts anti-tumor activity against breast cancer cells via inhibition of FGFR2.Peptide-coated gold nanoparticles for modulation of angiogenesis in vivoAddressing the Symptoms or Fixing the Problem? Developing Countermeasures against Normal Tissue Radiation Injury.Androgen receptor (AR) signaling promotes RCC progression via increased endothelial cell proliferation and recruitment by modulating AKT → NF-κB → CXCL5 signaling.Erlotinib for advanced hepatocellular carcinoma. A systematic review of phase II/III clinical trials.Dual roles of protein tyrosine phosphatase kappa in coordinating angiogenesis induced by pro-angiogenic factors.Hsp90β promoted endothelial cell-dependent tumor angiogenesis in hepatocellular carcinoma.MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2.An overview of tyrosine kinase inhibitors for the treatment of epithelial ovarian cancer.Effects of toceranib phosphate (Palladia) monotherapy on multidrug resistant lymphoma in dogs.KIF26B, a novel oncogene, promotes proliferation and metastasis by activating the VEGF pathway in gastric cancer.Antiangiogenic Effects of Nerve Growth Factor Loop 4 Monomeric Dipeptide Mimetic.Pharmacological Activities of Ruthenium Complexes Related to Their NO Scavenging PropertiesAngiogenesis in NSCLC: is vessel co-option the trunk that sustains the branches?Short peptides interfering with signaling pathways as new therapeutic tools for cancer treatment.Nanotherapy silencing the interleukin-8 gene produces regression of prostate cancer by inhibition of angiogenesis.RNAi-mediated downregulation of oral cancer overexpressed 1 (ORAOV1) inhibits vascular endothelial cell proliferation, migration, invasion, and tube formation.The Role of PDGFs and PDGFRs in Colorectal Cancer.Angiogenesis biomarkers and their targeting ligands as potential targets for tumor angiogenesis.Tumor angiogenesis revisited: Regulators and clinical implications.Cervical cancer systemic inflammation score: a novel predictor of prognosisDesign, synthesis, and evaluation of VEGFR-targeted macromolecular MRI contrast agent based on biotin-avidin-specific binding.Anti-angiogenic agents for the treatment of solid tumors: Potential pathways, therapy and current strategies - A review.Pharmacokinetics of calycopterin and xanthmicrol, two polymethoxylated hydroxyflavones with anti-angiogenic activities from Dracocephalum kotschyi Bioss.A systems medicine approach for finding target proteins affecting treatment outcomes in patients with non-Hodgkin lymphoma.Antitumor immunity induced by VE-cadherin modified DC vaccine.
P2860
Q26771513-62377EE7-1701-4E05-8B5F-D1C654B324A6Q26773408-72CF5B1C-8C06-4DFC-9790-E179D06DA8B6Q26801785-EB42970A-1664-4AB9-96DB-0DE516ECE811Q26801841-9F3179B2-B84B-4E96-9386-099D5472EF38Q27853358-33BBBFB1-7534-478E-9C72-6D924CACE22BQ28073155-FB9FB962-F29A-463C-B205-F9F40B857734Q28073613-368AB819-1644-454E-8806-B102A751CEE2Q33732986-D05FD1BF-2779-431E-9514-6B6D7A6EFF90Q33799297-A8612F36-66E0-4ACC-80C5-40AEBB276449Q33897971-053B961B-E72A-409A-882E-D328BBC21CB1Q35996844-5F00E085-96B2-410C-BB75-3FBFE3ACE619Q36334914-B385B7C9-FFA2-42DB-9001-A912708D0A36Q36390700-90562ACF-DFDD-4110-B010-78BF2B65A1D0Q36772187-54BEEED4-A74A-4B94-BAB7-432B2C1DF416Q36958382-F488D58F-E19C-48B0-9B85-3848ED2462C3Q37003836-FD43EA12-5157-45A5-931E-A5BF8B9924D5Q37189966-9F437A77-AD9C-4E50-8C49-9D8C856E3C78Q37416749-D985B81C-864C-42C6-9FC9-56149FE5BE0FQ37637658-3C8FED27-8F29-4E8D-B551-565F1FC54A05Q37718673-3814E89D-5892-49D0-83D2-DEAF6A9374B5Q37731561-86268FAF-27A7-43FA-B40D-78241D0EFD67Q37745389-8AE3D7B7-C5AC-4CBC-8C44-7BCB7BE0A6CFQ38631373-5742B1BD-D5CE-481D-BDC5-92F1A3F11AF1Q38737411-047B69E5-2557-4264-A29D-1C25F25D0901Q38743870-C803BA7C-00AB-4056-B37E-B3C0A22029F8Q38744423-07FB9251-3E45-44D6-816C-DD596CCE9A90Q38753875-00CF3B1E-2B10-4B32-B423-2A487C208E65Q38763633-B8F81470-CE4F-4994-B599-23BF53318207Q38767147-3301831E-7585-4B18-8855-7D2468BA1B06Q38772275-F63FBAA0-FA93-4CC7-9F56-0784827168AFQ38829362-7ECF1D8A-5018-4E99-BA5D-1D7511CFF615Q39120772-21A6C3FB-1FA2-4B79-82EB-7C55A8228BE6Q39368829-5CCFD8BC-066A-48B9-9242-2C092E6681DEQ39393740-D7B2FEC9-9DCF-4AF6-9F04-126EB87C3BA4Q39991182-47A42B69-8FF2-42FE-97A6-BE1CB663E06BQ41103676-CF1DBBC7-35ED-4F3B-99F8-98CD7C30BF12Q41258130-ECC3FFBB-C790-4AA8-AA34-9EF3182E202AQ41329829-4E93E890-F164-43C2-91E4-CE49C4D96B36Q41367937-65851FA5-8DC1-4A19-A0FF-F1CFD3C6F91AQ42366549-23A06F47-3F73-4981-8032-07C7A44BDDAF
P2860
Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Targeting Angiogenesis in Canc ...... lar Endothelial Growth Factor.
@en
type
label
Targeting Angiogenesis in Canc ...... lar Endothelial Growth Factor.
@en
prefLabel
Targeting Angiogenesis in Canc ...... lar Endothelial Growth Factor.
@en
P2860
P1433
P1476
Targeting Angiogenesis in Canc ...... lar Endothelial Growth Factor.
@en
P2093
Alex A Adjei
Yujie Zhao
P2860
P304
P356
10.1634/THEONCOLOGIST.2014-0465
P577
2015-05-22T00:00:00Z